US20110190873A1 - Stent - Google Patents

Stent Download PDF

Info

Publication number
US20110190873A1
US20110190873A1 US13/082,681 US201113082681A US2011190873A1 US 20110190873 A1 US20110190873 A1 US 20110190873A1 US 201113082681 A US201113082681 A US 201113082681A US 2011190873 A1 US2011190873 A1 US 2011190873A1
Authority
US
United States
Prior art keywords
strut
stent
segment
pairs
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/082,681
Inventor
Jason T. Lenz
Daniel Gregorich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Boston Scientific Scimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Scimed Inc filed Critical Boston Scientific Scimed Inc
Priority to US13/082,681 priority Critical patent/US20110190873A1/en
Publication of US20110190873A1 publication Critical patent/US20110190873A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91583Adjacent bands being connected to each other by a bridge, whereby at least one of its ends is connected along the length of a strut between two consecutive apices within a band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body
    • A61F2250/0068Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir

Definitions

  • This invention relates to an endoprosthesis device for implantation within a body vessel, typically a blood vessel. More specifically, it relates to a tubular expandable stent having improved structural aspects as well as improved drug retention/delivery capabilities.
  • Stents, grafts, stent-grafts, vena cava filters, expandable frameworks, and similar implantable medical devices, collectively referred to hereinafter as stents, are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously.
  • Stents may be implanted in a variety of body lumens or vessels such as within the vascular system, urinary tracts, bile ducts, fallopian tubes, coronary vessels, secondary vessels, etc.
  • Stents may be used to support body vessels and to prevent restenosis following angioplasty in the vascular system. They may be self-expanding, expanded by an internal radial force, such as when mounted on a balloon, or a combination of self-expanding and balloon expandable (hybrid expandable).
  • Stents may be created by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled, and/or from one or more interwoven wires or braids.
  • Known construction materials for use in stents include polymers, organic fabrics, and biocompatible metals.
  • Metals and/or alloys of such metals that have been used in the construction of stents and/or their components include but are not limited to: stainless steel, gold, silver, tantalum, titanium, chromium, cobalt and shape memory alloys such as Nitinol.
  • stents In an effort to combat vessel restenosis, as well as other medical conditions, stents have been employed to delivery a variety of therapeutic agents directly to the site of stent deployment. Some stents employ a variety of structural features, such as slots, grooves, holes, chambers, etc, to act as reservoirs for a therapeutic agent and/or other substances.
  • Embodiments of the present invention are directed to stent structures, which when used for the delivery of therapeutic agents such as drugs, provide improved drug delivery characteristics.
  • the unique arrangement and configuration of drug delivery reservoirs throughout the stent structure provide improved drug delivery characteristics without compromise to the stent's performance characteristics.
  • Embodiments of the present invention include stents, which have improved flexibility, but also sufficient structural strength to permit the stents to traverse the tortuous confines of mammalian anatomy.
  • the stent of the present invention are provided with strut bands of long and short struts, wherein pairs of short struts are connected to one another at junctions. The junctions provide a circumferential offset within the strut band.
  • the stents are provided with connectors between the strut bands, which have opposingly oriented U-shaped links, wherein each link extends from a junction of adjacent strut bands.
  • the combination of the structural features provided in the stents of the present invention provide a structurally improved, highly flexible stent.
  • An additional goal of the present invention is to provide stents with improved drug delivery characteristics as well. This goal is achieved by providing stents with drug delivery reservoirs that are positioned in and defined by the strut band junctions, as well as the connectors, and in some cases the struts as well. In some embodiments at least some of the reservoirs are provided in circumferentially aligned columns about the stent.
  • Reservoirs can be any type of surface feature suitable for containing a defined amount of therapeutic agent(s) such as a drug or drug/polymer matrix.
  • one or more of the reservoirs extend only partially through the thickness of the stent with only a single opening on either the inner surface (luminal) or outer surface (abluminal) of the stent.
  • one or more of the reservoirs is a through-hole which extends entirely through the thickness of the stent body.
  • Each reservoir can have a constant or varied cross-sectional area throughout its thicknesses.
  • Each reservoir opening can have any of a variety of sizes or shapes.
  • FIG. 1 shows a flat pattern view of an embodiment of the invention.
  • FIG. 2 shows a flat pattern view of an embodiment of the invention.
  • FIG. 3 shows a flat pattern view of an embodiment of the invention.
  • At least one embodiment of the present invention is directed to a stent 10 , an example of which is illustrated in FIG. 1 .
  • the structure of stent 10 is comprised of a plurality of strut bands 20 and connectors 40 .
  • Each strut band 20 forms a closed path of alternating peaks 22 and troughs 24 .
  • Strut bands 20 that are adjacent one another are connected by at least one connector 40 .
  • Each strut band 20 comprises a plurality of long struts 30 , a plurality of first short struts 32 and second short struts 34 , and a plurality of junctions 36 .
  • Each junction 36 is positioned between and connects a first short strut 32 and a second short strut 34 .
  • each first short strut 32 is longitudinally and circumferentially offset from each second short strut 34 .
  • Each long strut 30 is connected to a first short strut 32 at a peak 22 and to a second short strut 34 at a trough 24 .
  • each junction 36 defines a single junction reservoir 12 , wherein all of the junction reservoirs 12 of a given strut band 20 are substantially circumferentially aligned. In some embodiments however, a junction defines a plurality, such as 1, 2, 3, 4 or more junction reservoirs.
  • the connectors 40 comprise a first arm 42 which extends from a junction 36 on one strut band 20 and a second arm 46 which extends from a junction 36 on an adjacent strut band 20 .
  • At least a portion of the first arm 42 comprises a first U-shaped link 44 and at least a portion of the second arm 46 comprises a second U-shaped link 48 .
  • Each first U-shaped link 44 opens in a first direction and each second U-shaped link 48 opens in a second direction substantially opposite the first direction.
  • each link 44 and 48 opens in a substantially circumferential direction or substantially perpendicular to a longitudinal axis of the stent 10 .
  • At least a portion of the first U-shaped link 44 and at least a portion of the second U-shaped link 48 have a shared portion 50 .
  • the shared portion 50 of each connector 40 is disposed between one of the peaks 22 on one strut band 20 and a longitudinally adjacent trough 24 of an adjacent strut band 20 .
  • the shared portions 50 between any two strut bands 20 are substantially circumferentially aligned.
  • the strut bands 20 or a single continuous can be angled relative to a longitudinal axis of the stent to provide the band(s) with a helical or helical-like configuration.
  • the shared portions 50 of connectors 40 between a given pair of strut bands 40 can likewise be slanted or angled relative to the longitudinal axis.
  • each long strut 30 defines at least one strut reservoir 14 .
  • one or more of the long struts 30 define a plurality of strut reservoirs 14 .
  • the number of strut reservoirs 14 on a given long strut 30 can be varied from one to about twelve, depending on the length of the long strut 30 . In some embodiments the number of strut reservoirs 14 is between at least three to nine. In the embodiment depicted in FIG. 2 , in each long strut 30 one of the strut reservoirs 14 is in substantial circumferential alignment with the junction reservoirs 12 of a given strut band 20 .
  • the additional reservoirs 14 are spaced equidistantly from one another and are distributed evenly on either side of the central reservoir in circumferential alignment with the junction reservoirs 12 .
  • each long strut 30 has a long strut width, 31 and each first and second short strut 32 / 34 has a short strut width 33 .
  • the long strut width 31 is greater than the short strut width 33 .
  • long strut width 31 is substantially the same as the short strut width 33 .
  • each arm 42 and 46 of the connectors 40 have an arm width 45 .
  • the arm width is less than either the long strut width 31 or the short strut width 33 .
  • the width 45 of the arms 42 and 46 can vary along their lengths, particularly if the presence of connector reservoirs 16 necessitate a greater width region 47 in order to accommodate the desired cross-sectional area of the reservoirs 16 .
  • each connector 40 defines a single connector reservoir 16 .
  • the cross-sectional area 51 of a given connector reservoir 16 is greater than the cross-sectional area 53 of junction reservoir 12 or the cross-sectional area 55 of a strut reservoir 14 (areas 51 , 53 , and 55 are depicted shaded).
  • At least a portion of the first U-shaped link 44 , adjacent to the shared portion 50 defines at least one connector reservoir 16 and at least a portion of the second U-shaped link 48 , adjacent to the shared portion 50 , defines at least one connector reservoir 16 .
  • the area 51 of each connector reservoir is less than or substantially equal to the area 53 of each junction reservoir 12 .
  • first U-shaped link 44 and the second U-shaped link 48 each define a plurality of first connector reservoirs 16 a.
  • a region of the first arm 42 adjacent the first U-shaped link 44 and a region of the second arm 46 adjacent the second U-shaped link 48 each define a second plurality of connector reservoirs 16 b.
  • the first plurality 16 a is greater than the second plurality 16 b.
  • the particular configuration and arrangement of the connector reservoirs 16 is not limited to only those configurations/patterns shown in FIGS. 1-3 .
  • the distribution, size, shape and configuration of the connector reservoirs (as well as the junction reservoirs and strut reservoirs) can be modified, in order to provide desired distribution/elution characteristics of one or more drugs or other therapeutic agents.
  • a therapeutic agent may be a drug or other pharmaceutical product such as non-genetic agents, genetic agents, cellular material, etc.
  • suitable non-genetic therapeutic agents include but are not limited to: anti-thrombogenic agents such as heparin, heparin derivatives, vascular cell growth promoters, growth factor inhibitors, Paclitaxel, etc.
  • an agent includes a genetic therapeutic agent, such a genetic agent may include but is not limited to: DNA, RNA and their respective derivatives and/or components; hedgehog proteins, etc.
  • the cellular material may include but is not limited to: cells of human origin and/or non-human origin as well as their respective components and/or derivatives thereof.
  • the polymer agent may be a polystyrene-polyisobutylene-polystyrene triblock copolymer (SIBS), polyethylene oxide, silicone rubber and/or any other suitable substrate.
  • SIBS polystyrene-polyisobutylene-polystyrene triblock copolymer
  • the stent 10 shown and described herein may be made from any suitable biocompatible materials including one or more polymers, one or more metals or combinations of polymer(s) and metal(s).
  • suitable materials include biodegradable materials that are also biocompatible.
  • biodegradable is meant that a material will undergo breakdown or decomposition into harmless compounds as part of a normal biological process.
  • Suitable biodegradable materials include polylactic acid, polyglycolic acid (PGA), collagen or other connective proteins or natural materials, polycaprolactone, hylauric acid, adhesive proteins, co-polymers of these materials as well as composites and combinations thereof and combinations of other biodegradable polymers.
  • Other polymers that may be used include polyester and polycarbonate copolymers.
  • suitable metals include, but are not limited to, stainless steel, titanium, tantalum, platinum, tungsten, gold and alloys of any of the above-mentioned metals.
  • suitable alloys include, but are not limited to: platinum-iridium alloys, cobalt-chromium alloys, including Elgiloy and Phynox, MP35N alloy and nickel-titanium alloys, for example, Nitinol.
  • the stent 10 may be made of shape memory materials such as superelastic Nitinol or spring steel, or may be made of materials which are plastically deformable. In the case of shape memory materials, the stent may be provided with a memorized shape and then deformed to a reduced diameter shape. The stent 10 may restore itself to its memorized shape upon being heated to a transition temperature and having any restraints removed therefrom.
  • shape memory materials such as superelastic Nitinol or spring steel
  • the stent 10 may be manufactures by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled or from one or more interwoven wires or braids. Any other suitable technique which is known in the art or which is subsequently developed may also be used to manufacture the stent 10 disclosed herein.
  • the stent 10 may include one or more areas, bands, coatings, members, etc. that is (are) detectable by imaging modalities such as X-Ray, MRI, ultrasound, etc. In some embodiments at least a portion of the stent is at least partially radiopaque.
  • any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims).
  • each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims.
  • the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claim below.

Abstract

A stent with strut bands and connectors, wherein the strut bands have long and short struts with a junction positioned between the short struts. Each junction defines a reservoir, wherein the reservoirs of a strut band are substantially circumferentially aligned. The connectors each have arms, wherein each arm includes an opposing U-shaped link. The opposing links have a shared portion disposed between a peak on one strut band and a longitudinally adjacent trough of an adjacent strut band.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This Application is a continuation of U.S. patent application Ser. No. 12/783,781, Published as 2010/0222868, and filed on May 20, 2010, which is a division of U.S. patent application Ser. No. 11/960,333, filed on Dec. 19, 2007 and issued as U.S. Pat. No. 7,722,661, both of which are herein incorporated by reference.
  • STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH
  • Not Applicable
  • FIELD OF THE INVENTION
  • This invention relates to an endoprosthesis device for implantation within a body vessel, typically a blood vessel. More specifically, it relates to a tubular expandable stent having improved structural aspects as well as improved drug retention/delivery capabilities.
  • BACKGROUND OF THE INVENTION
  • Stents, grafts, stent-grafts, vena cava filters, expandable frameworks, and similar implantable medical devices, collectively referred to hereinafter as stents, are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously. Stents may be implanted in a variety of body lumens or vessels such as within the vascular system, urinary tracts, bile ducts, fallopian tubes, coronary vessels, secondary vessels, etc. Stents may be used to support body vessels and to prevent restenosis following angioplasty in the vascular system. They may be self-expanding, expanded by an internal radial force, such as when mounted on a balloon, or a combination of self-expanding and balloon expandable (hybrid expandable).
  • Stents may be created by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled, and/or from one or more interwoven wires or braids.
  • Known construction materials for use in stents include polymers, organic fabrics, and biocompatible metals. Metals and/or alloys of such metals that have been used in the construction of stents and/or their components include but are not limited to: stainless steel, gold, silver, tantalum, titanium, chromium, cobalt and shape memory alloys such as Nitinol.
  • In an effort to combat vessel restenosis, as well as other medical conditions, stents have been employed to delivery a variety of therapeutic agents directly to the site of stent deployment. Some stents employ a variety of structural features, such as slots, grooves, holes, chambers, etc, to act as reservoirs for a therapeutic agent and/or other substances.
  • There remains a need for drug delivery stents that have improved structural performance characteristics, such as improved flexibility, structural integrity, compression resistance, etc. There also remains a need to provide such stents with a more desirable drug delivery profile.
  • The art referred to and/or described above is not intended to constitute an admission that any patent, publication or other information referred to herein is “prior art” with respect to this invention. In addition, this section should not be construed to mean that a search has been made or that no other pertinent information as defined in 37 C.F.R. §1.56(a) exists.
  • All U.S. patents and applications and all other published documents mentioned anywhere in this application are incorporated herein by reference in their entirety.
  • Without limiting the scope of the invention a brief summary of some of the claimed embodiments of the invention is set forth below. Additional details of the summarized embodiments of the invention and/or additional embodiments of the invention may be found in the Detailed Description of the Invention below.
  • A brief abstract of the technical disclosure in the specification is provided as well only for the purposes of complying with 37 C.F.R. 1.72. The abstract is not intended to be used for interpreting the scope of the claims.
  • BRIEF SUMMARY OF THE INVENTION
  • Embodiments of the present invention are directed to stent structures, which when used for the delivery of therapeutic agents such as drugs, provide improved drug delivery characteristics. The unique arrangement and configuration of drug delivery reservoirs throughout the stent structure provide improved drug delivery characteristics without compromise to the stent's performance characteristics.
  • Embodiments of the present invention include stents, which have improved flexibility, but also sufficient structural strength to permit the stents to traverse the tortuous confines of mammalian anatomy. In some embodiments the stent of the present invention are provided with strut bands of long and short struts, wherein pairs of short struts are connected to one another at junctions. The junctions provide a circumferential offset within the strut band.
  • In some embodiments the stents are provided with connectors between the strut bands, which have opposingly oriented U-shaped links, wherein each link extends from a junction of adjacent strut bands.
  • The combination of the structural features provided in the stents of the present invention provide a structurally improved, highly flexible stent.
  • An additional goal of the present invention however, is to provide stents with improved drug delivery characteristics as well. This goal is achieved by providing stents with drug delivery reservoirs that are positioned in and defined by the strut band junctions, as well as the connectors, and in some cases the struts as well. In some embodiments at least some of the reservoirs are provided in circumferentially aligned columns about the stent.
  • Reservoirs can be any type of surface feature suitable for containing a defined amount of therapeutic agent(s) such as a drug or drug/polymer matrix. In some embodiments one or more of the reservoirs extend only partially through the thickness of the stent with only a single opening on either the inner surface (luminal) or outer surface (abluminal) of the stent. In some embodiments, one or more of the reservoirs is a through-hole which extends entirely through the thickness of the stent body. Each reservoir can have a constant or varied cross-sectional area throughout its thicknesses. Each reservoir opening can have any of a variety of sizes or shapes.
  • These and other embodiments which characterize the invention are pointed out with particularity in the claims annexed hereto and forming a part hereof. However, for further understanding of the invention, its advantages and objectives obtained by its use, reference can be made to the drawings which form a further part hereof and the accompanying descriptive matter, in which there is illustrated and described a embodiments of the invention.
  • BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING(S)
  • A detailed description of the invention is hereafter described with specific reference being made to the drawings.
  • FIG. 1 shows a flat pattern view of an embodiment of the invention.
  • FIG. 2 shows a flat pattern view of an embodiment of the invention.
  • FIG. 3 shows a flat pattern view of an embodiment of the invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • While this invention may be embodied in many different forms, there are described in detail herein specific embodiments of the invention. This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
  • For the purposes of this disclosure, like reference numerals in the figures shall refer to like features unless otherwise indicated.
  • At least one embodiment of the present invention is directed to a stent 10, an example of which is illustrated in FIG. 1. The structure of stent 10 is comprised of a plurality of strut bands 20 and connectors 40.
  • Each strut band 20 forms a closed path of alternating peaks 22 and troughs 24. Strut bands 20 that are adjacent one another are connected by at least one connector 40.
  • Each strut band 20 comprises a plurality of long struts 30, a plurality of first short struts 32 and second short struts 34, and a plurality of junctions 36. Each junction 36 is positioned between and connects a first short strut 32 and a second short strut 34. In the embodiments depicted in FIGS. 1-3, within each strut band 20 each first short strut 32 is longitudinally and circumferentially offset from each second short strut 34. Each long strut 30 is connected to a first short strut 32 at a peak 22 and to a second short strut 34 at a trough 24.
  • In the various embodiments shown in FIGS. 1-3 each junction 36 defines a single junction reservoir 12, wherein all of the junction reservoirs 12 of a given strut band 20 are substantially circumferentially aligned. In some embodiments however, a junction defines a plurality, such as 1, 2, 3, 4 or more junction reservoirs.
  • In some embodiments, the connectors 40 comprise a first arm 42 which extends from a junction 36 on one strut band 20 and a second arm 46 which extends from a junction 36 on an adjacent strut band 20. At least a portion of the first arm 42 comprises a first U-shaped link 44 and at least a portion of the second arm 46 comprises a second U-shaped link 48. Each first U-shaped link 44 opens in a first direction and each second U-shaped link 48 opens in a second direction substantially opposite the first direction. Though the specific orientation of the opening of the links can be varied and in any direction, in the embodiments shown in FIG. 1-3, each link 44 and 48 opens in a substantially circumferential direction or substantially perpendicular to a longitudinal axis of the stent 10.
  • At least a portion of the first U-shaped link 44 and at least a portion of the second U-shaped link 48 have a shared portion 50. The shared portion 50 of each connector 40 is disposed between one of the peaks 22 on one strut band 20 and a longitudinally adjacent trough 24 of an adjacent strut band 20. In embodiments where the stent 10 includes a plurality of connectors 40 between adjacent strut bands 20, the shared portions 50 between any two strut bands 20 are substantially circumferentially aligned.
  • If desired the strut bands 20 or a single continuous can be angled relative to a longitudinal axis of the stent to provide the band(s) with a helical or helical-like configuration. In such an embodiment the shared portions 50 of connectors 40 between a given pair of strut bands 40 can likewise be slanted or angled relative to the longitudinal axis.
  • In the embodiment depicted in FIG. 2 each long strut 30 defines at least one strut reservoir 14. In some embodiments, one or more of the long struts 30 define a plurality of strut reservoirs 14. The number of strut reservoirs 14 on a given long strut 30 can be varied from one to about twelve, depending on the length of the long strut 30. In some embodiments the number of strut reservoirs 14 is between at least three to nine. In the embodiment depicted in FIG. 2, in each long strut 30 one of the strut reservoirs 14 is in substantial circumferential alignment with the junction reservoirs 12 of a given strut band 20. Where there is a plurality of strut reservoirs 14 on a long strut 30, preferably the additional reservoirs 14 are spaced equidistantly from one another and are distributed evenly on either side of the central reservoir in circumferential alignment with the junction reservoirs 12.
  • The various components of a stent (struts, connectors, reservoirs, etc.) can have a variety of physical characteristics, such as length, width, thickness, etc, of which each can also be varied. In the embodiments depicted in FIG. 2 however, each long strut 30 has a long strut width, 31 and each first and second short strut 32/34 has a short strut width 33. The long strut width 31 is greater than the short strut width 33. Alternatively, in the embodiment shown in FIGS. 1 & 3 long strut width 31 is substantially the same as the short strut width 33.
  • In some embodiments, such as those shown in FIGS. 1 and 2, each arm 42 and 46 of the connectors 40 have an arm width 45. The arm width is less than either the long strut width 31 or the short strut width 33. In at least one embodiment, such as is depicted in FIG. 3, the width 45 of the arms 42 and 46 can vary along their lengths, particularly if the presence of connector reservoirs 16 necessitate a greater width region 47 in order to accommodate the desired cross-sectional area of the reservoirs 16.
  • In some embodiments, such as for example those depicted in FIGS. 1-2 the shared portion 50 of each connector 40 defines a single connector reservoir 16. As can be seen in the illustrations, the cross-sectional area 51 of a given connector reservoir 16 is greater than the cross-sectional area 53 of junction reservoir 12 or the cross-sectional area 55 of a strut reservoir 14 ( areas 51, 53, and 55 are depicted shaded).
  • In some embodiments such as in the stent 10 depicted in FIG. 3, at least a portion of the first U-shaped link 44, adjacent to the shared portion 50, defines at least one connector reservoir 16 and at least a portion of the second U-shaped link 48, adjacent to the shared portion 50, defines at least one connector reservoir 16. In the embodiment shown, the area 51 of each connector reservoir is less than or substantially equal to the area 53 of each junction reservoir 12.
  • In the embodiment depicted in FIG. 3 the first U-shaped link 44 and the second U-shaped link 48 each define a plurality of first connector reservoirs 16 a. A region of the first arm 42 adjacent the first U-shaped link 44 and a region of the second arm 46 adjacent the second U-shaped link 48 each define a second plurality of connector reservoirs 16 b. The first plurality 16 a is greater than the second plurality 16 b.
  • The particular configuration and arrangement of the connector reservoirs 16 is not limited to only those configurations/patterns shown in FIGS. 1-3. The distribution, size, shape and configuration of the connector reservoirs (as well as the junction reservoirs and strut reservoirs) can be modified, in order to provide desired distribution/elution characteristics of one or more drugs or other therapeutic agents.
  • A therapeutic agent may be a drug or other pharmaceutical product such as non-genetic agents, genetic agents, cellular material, etc. Some examples of suitable non-genetic therapeutic agents include but are not limited to: anti-thrombogenic agents such as heparin, heparin derivatives, vascular cell growth promoters, growth factor inhibitors, Paclitaxel, etc. Where an agent includes a genetic therapeutic agent, such a genetic agent may include but is not limited to: DNA, RNA and their respective derivatives and/or components; hedgehog proteins, etc. Where a therapeutic agent includes cellular material, the cellular material may include but is not limited to: cells of human origin and/or non-human origin as well as their respective components and/or derivatives thereof. Where the therapeutic agent includes a polymer agent, the polymer agent may be a polystyrene-polyisobutylene-polystyrene triblock copolymer (SIBS), polyethylene oxide, silicone rubber and/or any other suitable substrate.
  • The stent 10 shown and described herein may be made from any suitable biocompatible materials including one or more polymers, one or more metals or combinations of polymer(s) and metal(s). Examples of suitable materials include biodegradable materials that are also biocompatible. By biodegradable is meant that a material will undergo breakdown or decomposition into harmless compounds as part of a normal biological process. Suitable biodegradable materials include polylactic acid, polyglycolic acid (PGA), collagen or other connective proteins or natural materials, polycaprolactone, hylauric acid, adhesive proteins, co-polymers of these materials as well as composites and combinations thereof and combinations of other biodegradable polymers. Other polymers that may be used include polyester and polycarbonate copolymers. Examples of suitable metals include, but are not limited to, stainless steel, titanium, tantalum, platinum, tungsten, gold and alloys of any of the above-mentioned metals. Examples of suitable alloys include, but are not limited to: platinum-iridium alloys, cobalt-chromium alloys, including Elgiloy and Phynox, MP35N alloy and nickel-titanium alloys, for example, Nitinol.
  • The stent 10 may be made of shape memory materials such as superelastic Nitinol or spring steel, or may be made of materials which are plastically deformable. In the case of shape memory materials, the stent may be provided with a memorized shape and then deformed to a reduced diameter shape. The stent 10 may restore itself to its memorized shape upon being heated to a transition temperature and having any restraints removed therefrom.
  • The stent 10 may be manufactures by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled or from one or more interwoven wires or braids. Any other suitable technique which is known in the art or which is subsequently developed may also be used to manufacture the stent 10 disclosed herein.
  • In some embodiments the stent 10, or its delivery system, may include one or more areas, bands, coatings, members, etc. that is (are) detectable by imaging modalities such as X-Ray, MRI, ultrasound, etc. In some embodiments at least a portion of the stent is at least partially radiopaque.
  • The above disclosure is intended to be illustrative and not exhaustive. This description will suggest many variations and alternatives to one of ordinary skill in this art. The various elements shown in the individual figures and described above may be combined or modified for combination as desired. All these alternatives and variations are intended to be included within the scope of the claims where the term “comprising” means “including, but not limited to”.
  • Further, the particular features presented in the dependent claims can be combined with each other in other manners within the scope of the invention such that the invention should be recognized as also specifically directed to other embodiments having any other possible combination of the features of the dependent claims. For instance, for purposes of claim publication, any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims). In jurisdictions where multiple dependent claim formats are restricted, the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claim below.
  • This completes the description of the invention. Those skilled in the art may recognize other equivalents to the specific embodiment described herein which equivalents are intended to be encompassed by the claims attached hereto.

Claims (13)

1. A stent comprising:
a cylindrical body comprising a plurality of strut pairs having a first lateral side and a second lateral side, the first lateral side comprising a first straight strut segment and the second lateral side comprising a second straight strut segment, the first straight strut segment being circumferentially offset from the second straight strut segment; and
a plurality of connectors, the connectors connecting longitudinally adjacent strut pairs one to another, wherein the connectors have a first end and a second end, the first end being connected to the first straight strut segment and the second end being connected to the first straight strut segment of a longitudinally adjacent strut pair, the first end being longitudinally and circumferentially offset from the second end;
the first straight strut segment and the second straight strut segment each comprise at least one reservoir, the first straight strut segments having a different number of reservoirs than the second straight strut segments and the reservoirs having therein a therapeutic agent;
wherein the strut pairs include first strut pairs and second strut pairs, first strut pairs being longitudinally offset from second strut pairs, first lateral sides of the first strut pairs being circumferentially aligned with second lateral sides of second strut pairs.
2. The stent of claim 1, wherein the connectors have a connector width that is less than the width of the first straight strut segment.
3. The stent of claim 1, wherein the therapeutic agent includes a polymeric material and a drug.
4. The stent of claim 1, wherein the second straight strut segment has between one and twelve reservoirs.
5. The stent of claim 1, wherein the stent is metallic.
6. The stent of claim 1, wherein the connectors comprise at least one curved portion.
7. The stent of claim 1, wherein the first straight strut segment is connected to the second straight strut segment via a curved segment.
8. The stent of claim 7, wherein circumferentially adjacent strut pairs are connected to one another via a curved segment.
9. The stent of claim 1, wherein the at least one band comprises a serpentine pattern.
10. A stent comprising:
a band comprising a plurality of strut pairs having a first strut segment and a second strut segment, the first strut segments being circumferentially offset from the second strut segments;
a plurality of connectors, the connectors connecting longitudinally adjacent strut pairs to one another, wherein the connectors have first ends and second ends, the first ends being connected to a first strut segment and the second ends being connected to a first strut segment, the first end being contralateral to the second end;
wherein the first strut segment and the second strut segment each comprise at least one reservoir, the first strut segments having a different number of reservoirs than the second strut segments and the reservoirs having therein a therapeutic agent.
11. The stent of claim 10, the strut pairs comprise first strut pairs and second strut pairs, the first strut pairs being longitudinally offset from the second strut pairs, wherein each of the first and second strut pairs comprises a first lateral side and a second lateral side, the first lateral side of the first strut pair being circumferentially aligned with the second lateral side of the longitudinally adjacent second strut pair.
12. The stent of claim 11, wherein the stent is metallic.
13. The stent of claim 10, wherein the band is helical.
US13/082,681 2007-12-19 2011-04-08 Stent Abandoned US20110190873A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/082,681 US20110190873A1 (en) 2007-12-19 2011-04-08 Stent

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/960,333 US7722661B2 (en) 2007-12-19 2007-12-19 Stent
US12/783,781 US7922756B2 (en) 2007-12-19 2010-05-20 Stent
US13/082,681 US20110190873A1 (en) 2007-12-19 2011-04-08 Stent

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/783,781 Continuation US7922756B2 (en) 2007-12-19 2010-05-20 Stent

Publications (1)

Publication Number Publication Date
US20110190873A1 true US20110190873A1 (en) 2011-08-04

Family

ID=40262667

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/960,333 Expired - Fee Related US7722661B2 (en) 2007-12-19 2007-12-19 Stent
US12/783,781 Expired - Fee Related US7922756B2 (en) 2007-12-19 2010-05-20 Stent
US13/082,681 Abandoned US20110190873A1 (en) 2007-12-19 2011-04-08 Stent

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US11/960,333 Expired - Fee Related US7722661B2 (en) 2007-12-19 2007-12-19 Stent
US12/783,781 Expired - Fee Related US7922756B2 (en) 2007-12-19 2010-05-20 Stent

Country Status (7)

Country Link
US (3) US7722661B2 (en)
EP (1) EP2231079B1 (en)
JP (1) JP2011507604A (en)
CN (1) CN101902993A (en)
AT (1) ATE550000T1 (en)
CA (1) CA2708619A1 (en)
WO (1) WO2009079132A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120029622A1 (en) * 2010-08-02 2012-02-02 Baillargeon Brian P Flexible helical stent having different helical regions

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070219642A1 (en) * 1998-12-03 2007-09-20 Jacob Richter Hybrid stent having a fiber or wire backbone
US8382821B2 (en) 1998-12-03 2013-02-26 Medinol Ltd. Helical hybrid stent
US20040267349A1 (en) * 2003-06-27 2004-12-30 Kobi Richter Amorphous metal alloy medical devices
US7169178B1 (en) * 2002-11-12 2007-01-30 Advanced Cardiovascular Systems, Inc. Stent with drug coating
US9155639B2 (en) * 2009-04-22 2015-10-13 Medinol Ltd. Helical hybrid stent
US9039755B2 (en) 2003-06-27 2015-05-26 Medinol Ltd. Helical hybrid stent
US20060127443A1 (en) * 2004-12-09 2006-06-15 Helmus Michael N Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
WO2008002778A2 (en) 2006-06-29 2008-01-03 Boston Scientific Limited Medical devices with selective coating
JP2010503469A (en) 2006-09-14 2010-02-04 ボストン サイエンティフィック リミテッド Medical device having drug-eluting film
US20080294236A1 (en) * 2007-05-23 2008-11-27 Boston Scientific Scimed, Inc. Endoprosthesis with Select Ceramic and Polymer Coatings
US8431149B2 (en) * 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
EP2187988B1 (en) * 2007-07-19 2013-08-21 Boston Scientific Limited Endoprosthesis having a non-fouling surface
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US8221822B2 (en) 2007-07-31 2012-07-17 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
JP2010535541A (en) 2007-08-03 2010-11-25 ボストン サイエンティフィック リミテッド Coating for medical devices with large surface area
US20090118812A1 (en) * 2007-11-02 2009-05-07 Boston Scientific Scimed, Inc. Endoprosthesis coating
US20090118821A1 (en) * 2007-11-02 2009-05-07 Boston Scientific Scimed, Inc. Endoprosthesis with porous reservoir and non-polymer diffusion layer
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US20090118818A1 (en) * 2007-11-02 2009-05-07 Boston Scientific Scimed, Inc. Endoprosthesis with coating
US7722661B2 (en) * 2007-12-19 2010-05-25 Boston Scientific Scimed, Inc. Stent
EP2271380B1 (en) 2008-04-22 2013-03-20 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
US8932346B2 (en) 2008-04-24 2015-01-13 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US8114151B2 (en) * 2008-05-08 2012-02-14 Boston Scientific Scimed, Inc. Stent with tabs and holes for drug delivery
US8449603B2 (en) 2008-06-18 2013-05-28 Boston Scientific Scimed, Inc. Endoprosthesis coating
CN101732114B (en) * 2008-11-04 2014-07-30 上海微创医疗器械(集团)有限公司 Coronary artery stent with medicine carrying grooves
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
RU2567831C2 (en) 2009-02-02 2015-11-10 Кордис Корпорейшн Construction of flexible stent
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
WO2011056981A2 (en) 2009-11-04 2011-05-12 Nitinol Devices And Components, Inc. Alternating circumferential bridge stent design and methods for use thereof
US9301864B2 (en) 2010-06-08 2016-04-05 Veniti, Inc. Bi-directional stent delivery system
US8864811B2 (en) 2010-06-08 2014-10-21 Veniti, Inc. Bi-directional stent delivery system
AU2011285804B2 (en) * 2010-08-02 2015-01-22 Cardinal Health 529, Llc Flexible helical stent having intermediate structural feature
CA2807018C (en) * 2010-08-02 2016-05-24 Cordis Corporation Flexible helical stent having intermediate structural feature
KR101961531B1 (en) * 2010-08-02 2019-07-17 코디스 코포레이션 A tubular flexible stent having helical sections
US9233014B2 (en) 2010-09-24 2016-01-12 Veniti, Inc. Stent with support braces
WO2012047308A1 (en) 2010-10-08 2012-04-12 Nitinol Devices And Components, Inc. Alternating circumferential bridge stent design and methods for use thereof
EP2680797B1 (en) * 2011-03-03 2016-10-26 Boston Scientific Scimed, Inc. Low strain high strength stent
WO2012125184A1 (en) * 2011-03-16 2012-09-20 Boston Scientific Scimed, Inc. Stent and delivery system
JP6220386B2 (en) 2012-05-14 2017-10-25 シー・アール・バード・インコーポレーテッドC R Bard Incorporated Uniformly expandable stent
US20140121750A1 (en) * 2012-10-31 2014-05-01 Cook Medical Technologies Llc Fixation Process For Nesting Stents
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
US10271975B2 (en) 2013-03-15 2019-04-30 Atrium Medical Corporation Stent device having reduced foreshortening and recoil and method of making same
WO2015007435A1 (en) * 2013-07-19 2015-01-22 Biotronik Ag Stent
US10835398B2 (en) * 2017-11-03 2020-11-17 Covidien Lp Meshes and devices for treating vascular defects

Citations (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US5139480A (en) * 1990-08-22 1992-08-18 Biotech Laboratories, Inc. Necking stents
US5183085A (en) * 1991-09-27 1993-02-02 Hans Timmermans Method and apparatus for compressing a stent prior to insertion
US5195984A (en) * 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US5242399A (en) * 1990-04-25 1993-09-07 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5314444A (en) * 1987-03-13 1994-05-24 Cook Incorporated Endovascular stent and delivery system
US5421955A (en) * 1991-10-28 1995-06-06 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5425739A (en) * 1989-03-09 1995-06-20 Avatar Design And Development, Inc. Anastomosis stent and stent selection system
US5441515A (en) * 1993-04-23 1995-08-15 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US5443477A (en) * 1994-02-10 1995-08-22 Stentco, Inc. Apparatus and method for deployment of radially expandable stents by a mechanical linkage
US5494029A (en) * 1992-09-29 1996-02-27 Hood Laboratories Laryngeal stents
US5496277A (en) * 1990-04-12 1996-03-05 Schneider (Usa) Inc. Radially expandable body implantable device
US5507767A (en) * 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
US5507771A (en) * 1992-06-15 1996-04-16 Cook Incorporated Stent assembly
US5522882A (en) * 1994-10-21 1996-06-04 Impra, Inc. Method and apparatus for balloon expandable stent-graft delivery
US5531741A (en) * 1994-08-18 1996-07-02 Barbacci; Josephine A. Illuminated stents
US5549662A (en) * 1994-11-07 1996-08-27 Scimed Life Systems, Inc. Expandable stent using sliding members
US5741293A (en) * 1995-11-28 1998-04-21 Wijay; Bandula Locking stent
US5797898A (en) * 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US5824040A (en) * 1995-12-01 1998-10-20 Medtronic, Inc. Endoluminal prostheses and therapies for highly variable body lumens
US5824037A (en) * 1995-10-03 1998-10-20 Medtronic, Inc. Modular intraluminal prostheses construction and methods
US5891108A (en) * 1994-09-12 1999-04-06 Cordis Corporation Drug delivery stent
US5902499A (en) * 1994-05-30 1999-05-11 Richerzhagen; Bernold Method and apparatus for machining material with a liquid-guided laser beam
US5925061A (en) * 1997-01-13 1999-07-20 Gore Enterprise Holdings, Inc. Low profile vascular stent
US5972027A (en) * 1997-09-30 1999-10-26 Scimed Life Systems, Inc Porous stent drug delivery system
US6071305A (en) * 1996-11-25 2000-06-06 Alza Corporation Directional drug delivery stent and method of use
US6132461A (en) * 1998-03-27 2000-10-17 Intratherapeutics, Inc. Stent with dual support structure
US6156062A (en) * 1997-12-03 2000-12-05 Ave Connaught Helically wrapped interlocking stent
US6206915B1 (en) * 1998-09-29 2001-03-27 Medtronic Ave, Inc. Drug storing and metering stent
US6231598B1 (en) * 1997-09-24 2001-05-15 Med Institute, Inc. Radially expandable stent
US6241762B1 (en) * 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6254632B1 (en) * 2000-09-28 2001-07-03 Advanced Cardiovascular Systems, Inc. Implantable medical device having protruding surface structures for drug delivery and cover attachment
US6273908B1 (en) * 1997-10-24 2001-08-14 Robert Ndondo-Lay Stents
US6273913B1 (en) * 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US6355055B1 (en) * 1995-09-01 2002-03-12 Emory University Endovascular support device and method of use
US20020038146A1 (en) * 1998-07-29 2002-03-28 Ulf Harry Expandable stent with relief cuts for carrying medicines and other materials
US6379382B1 (en) * 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
US6379381B1 (en) * 1999-09-03 2002-04-30 Advanced Cardiovascular Systems, Inc. Porous prosthesis and a method of depositing substances into the pores
US6387124B1 (en) * 1991-10-04 2002-05-14 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US6395326B1 (en) * 2000-05-31 2002-05-28 Advanced Cardiovascular Systems, Inc. Apparatus and method for depositing a coating onto a surface of a prosthesis
US6506437B1 (en) * 2000-10-17 2003-01-14 Advanced Cardiovascular Systems, Inc. Methods of coating an implantable device having depots formed in a surface thereof
US6551838B2 (en) * 2000-03-02 2003-04-22 Microchips, Inc. Microfabricated devices for the storage and selective exposure of chemicals and devices
US6558733B1 (en) * 2000-10-26 2003-05-06 Advanced Cardiovascular Systems, Inc. Method for etching a micropatterned microdepot prosthesis
US20030125803A1 (en) * 2001-11-13 2003-07-03 Franco Vallana Carrier and kit for intraluminal delivery of active principles or agents
US6635082B1 (en) * 2000-12-29 2003-10-21 Advanced Cardiovascular Systems Inc. Radiopaque stent
US6656162B2 (en) * 1999-11-17 2003-12-02 Microchips, Inc. Implantable drug delivery stents
US6660034B1 (en) * 2001-04-30 2003-12-09 Advanced Cardiovascular Systems, Inc. Stent for increasing blood flow to ischemic tissues and a method of using the same
US6663664B1 (en) * 2000-10-26 2003-12-16 Advanced Cardiovascular Systems, Inc. Self-expanding stent with time variable radial force
US6663662B2 (en) * 2000-12-28 2003-12-16 Advanced Cardiovascular Systems, Inc. Diffusion barrier layer for implantable devices
US20040024449A1 (en) * 2000-11-17 2004-02-05 Boyle Christhoper T. Device for in vivo delivery of bioactive agents and method of manufacture thereof
US20040034337A1 (en) * 2002-08-16 2004-02-19 Boulais Dennis R. Microarray drug delivery coatings
US6699281B2 (en) * 2001-07-20 2004-03-02 Sorin Biomedica Cardio S.P.A. Angioplasty stents
US20040044401A1 (en) * 2002-08-30 2004-03-04 Bales Thomas O. Helical stent having improved flexibility and expandability
US6709379B1 (en) * 1998-11-02 2004-03-23 Alcove Surfaces Gmbh Implant with cavities containing therapeutic agents
US6758859B1 (en) * 2000-10-30 2004-07-06 Kenny L. Dang Increased drug-loading and reduced stress drug delivery device
US6783543B2 (en) * 2000-06-05 2004-08-31 Scimed Life Systems, Inc. Intravascular stent with increasing coating retaining capacity
US6790227B2 (en) * 2001-03-01 2004-09-14 Cordis Corporation Flexible stent
US20040204750A1 (en) * 2003-04-08 2004-10-14 Medtronic Ave. Drug-eluting stent for controlled drug delivery
US20040254635A1 (en) * 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
US6849089B2 (en) * 2001-10-08 2005-02-01 Biotronik Mess-Und Therapiegeraete Gmbh & Co Ingenieurbuero Berlin Implant with proliferation-inhibiting substance
US7014654B2 (en) * 2001-11-30 2006-03-21 Scimed Life Systems, Inc. Stent designed for the delivery of therapeutic substance or other agents
US20060224234A1 (en) * 2001-08-29 2006-10-05 Swaminathan Jayaraman Drug eluting structurally variable stent
US7135039B2 (en) * 2000-03-06 2006-11-14 Boston Scientific Scimed, Inc. Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof
US7922756B2 (en) * 2007-12-19 2011-04-12 Boston Scientific Scimed, Inc. Stent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464650A (en) 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
US5609629A (en) 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
WO1998051238A1 (en) 1997-05-14 1998-11-19 Novo Rps Ulc Expandable stent and method for production of same
US6179867B1 (en) 1998-01-16 2001-01-30 Advanced Cardiovascular Systems, Inc. Flexible stent and method of use
DE19916086B4 (en) 1998-04-11 2004-11-11 Inflow Dynamics Inc. Implantable prosthesis, especially vascular prosthesis (stent)
WO1999056907A1 (en) 1998-04-30 1999-11-11 Synova S.A. Material shaping device with a laser beam which is injected into a stream of liquid
US7077859B2 (en) 2000-12-22 2006-07-18 Avantec Vascular Corporation Apparatus and methods for variably controlled substance delivery from implanted prostheses
AU2002339717A1 (en) 2001-10-18 2003-07-15 Advanced Stent Technologies, Inc. Stent for vessel support, coverage and side branch accessibility
US6828696B2 (en) * 2002-07-03 2004-12-07 Fusion Uv Systems, Inc. Apparatus and method for powering multiple magnetrons using a single power supply

Patent Citations (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4733665B1 (en) * 1985-11-07 1994-01-11 Expandable Grafts Partnership Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5314444A (en) * 1987-03-13 1994-05-24 Cook Incorporated Endovascular stent and delivery system
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US5195984A (en) * 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US5425739A (en) * 1989-03-09 1995-06-20 Avatar Design And Development, Inc. Anastomosis stent and stent selection system
US5496277A (en) * 1990-04-12 1996-03-05 Schneider (Usa) Inc. Radially expandable body implantable device
US5242399A (en) * 1990-04-25 1993-09-07 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5139480A (en) * 1990-08-22 1992-08-18 Biotech Laboratories, Inc. Necking stents
US5183085A (en) * 1991-09-27 1993-02-02 Hans Timmermans Method and apparatus for compressing a stent prior to insertion
US6387124B1 (en) * 1991-10-04 2002-05-14 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5421955A (en) * 1991-10-28 1995-06-06 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5514154A (en) * 1991-10-28 1996-05-07 Advanced Cardiovascular Systems, Inc. Expandable stents
US5603721A (en) * 1991-10-28 1997-02-18 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5421955B1 (en) * 1991-10-28 1998-01-20 Advanced Cardiovascular System Expandable stents and method for making same
US5507767A (en) * 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
US5507771A (en) * 1992-06-15 1996-04-16 Cook Incorporated Stent assembly
US5494029A (en) * 1992-09-29 1996-02-27 Hood Laboratories Laryngeal stents
US5441515A (en) * 1993-04-23 1995-08-15 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US5443477A (en) * 1994-02-10 1995-08-22 Stentco, Inc. Apparatus and method for deployment of radially expandable stents by a mechanical linkage
US5902499A (en) * 1994-05-30 1999-05-11 Richerzhagen; Bernold Method and apparatus for machining material with a liquid-guided laser beam
US5531741A (en) * 1994-08-18 1996-07-02 Barbacci; Josephine A. Illuminated stents
US5891108A (en) * 1994-09-12 1999-04-06 Cordis Corporation Drug delivery stent
US5902266A (en) * 1994-09-12 1999-05-11 Cordis Corporation Method for delivering a liquid solution to the interior wall surface of a vessel
US5522882A (en) * 1994-10-21 1996-06-04 Impra, Inc. Method and apparatus for balloon expandable stent-graft delivery
US5549662A (en) * 1994-11-07 1996-08-27 Scimed Life Systems, Inc. Expandable stent using sliding members
US6355055B1 (en) * 1995-09-01 2002-03-12 Emory University Endovascular support device and method of use
US5824037A (en) * 1995-10-03 1998-10-20 Medtronic, Inc. Modular intraluminal prostheses construction and methods
US5741293A (en) * 1995-11-28 1998-04-21 Wijay; Bandula Locking stent
US5824040A (en) * 1995-12-01 1998-10-20 Medtronic, Inc. Endoluminal prostheses and therapies for highly variable body lumens
US5797898A (en) * 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US6071305A (en) * 1996-11-25 2000-06-06 Alza Corporation Directional drug delivery stent and method of use
US5925061A (en) * 1997-01-13 1999-07-20 Gore Enterprise Holdings, Inc. Low profile vascular stent
US6273913B1 (en) * 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US6231598B1 (en) * 1997-09-24 2001-05-15 Med Institute, Inc. Radially expandable stent
US5972027A (en) * 1997-09-30 1999-10-26 Scimed Life Systems, Inc Porous stent drug delivery system
US6273908B1 (en) * 1997-10-24 2001-08-14 Robert Ndondo-Lay Stents
US6156062A (en) * 1997-12-03 2000-12-05 Ave Connaught Helically wrapped interlocking stent
US6132461A (en) * 1998-03-27 2000-10-17 Intratherapeutics, Inc. Stent with dual support structure
US6241762B1 (en) * 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6562065B1 (en) * 1998-03-30 2003-05-13 Conor Medsystems, Inc. Expandable medical device with beneficial agent delivery mechanism
US20040254635A1 (en) * 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
US20020038146A1 (en) * 1998-07-29 2002-03-28 Ulf Harry Expandable stent with relief cuts for carrying medicines and other materials
US6206915B1 (en) * 1998-09-29 2001-03-27 Medtronic Ave, Inc. Drug storing and metering stent
US6709379B1 (en) * 1998-11-02 2004-03-23 Alcove Surfaces Gmbh Implant with cavities containing therapeutic agents
US6379381B1 (en) * 1999-09-03 2002-04-30 Advanced Cardiovascular Systems, Inc. Porous prosthesis and a method of depositing substances into the pores
US6656162B2 (en) * 1999-11-17 2003-12-02 Microchips, Inc. Implantable drug delivery stents
US6551838B2 (en) * 2000-03-02 2003-04-22 Microchips, Inc. Microfabricated devices for the storage and selective exposure of chemicals and devices
US7135039B2 (en) * 2000-03-06 2006-11-14 Boston Scientific Scimed, Inc. Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof
US6379382B1 (en) * 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
US6395326B1 (en) * 2000-05-31 2002-05-28 Advanced Cardiovascular Systems, Inc. Apparatus and method for depositing a coating onto a surface of a prosthesis
US6783543B2 (en) * 2000-06-05 2004-08-31 Scimed Life Systems, Inc. Intravascular stent with increasing coating retaining capacity
US6254632B1 (en) * 2000-09-28 2001-07-03 Advanced Cardiovascular Systems, Inc. Implantable medical device having protruding surface structures for drug delivery and cover attachment
US6506437B1 (en) * 2000-10-17 2003-01-14 Advanced Cardiovascular Systems, Inc. Methods of coating an implantable device having depots formed in a surface thereof
US6663664B1 (en) * 2000-10-26 2003-12-16 Advanced Cardiovascular Systems, Inc. Self-expanding stent with time variable radial force
US6558733B1 (en) * 2000-10-26 2003-05-06 Advanced Cardiovascular Systems, Inc. Method for etching a micropatterned microdepot prosthesis
US6758859B1 (en) * 2000-10-30 2004-07-06 Kenny L. Dang Increased drug-loading and reduced stress drug delivery device
US20040024449A1 (en) * 2000-11-17 2004-02-05 Boyle Christhoper T. Device for in vivo delivery of bioactive agents and method of manufacture thereof
US6663662B2 (en) * 2000-12-28 2003-12-16 Advanced Cardiovascular Systems, Inc. Diffusion barrier layer for implantable devices
US6635082B1 (en) * 2000-12-29 2003-10-21 Advanced Cardiovascular Systems Inc. Radiopaque stent
US6790227B2 (en) * 2001-03-01 2004-09-14 Cordis Corporation Flexible stent
US6660034B1 (en) * 2001-04-30 2003-12-09 Advanced Cardiovascular Systems, Inc. Stent for increasing blood flow to ischemic tissues and a method of using the same
US6699281B2 (en) * 2001-07-20 2004-03-02 Sorin Biomedica Cardio S.P.A. Angioplasty stents
US20060224234A1 (en) * 2001-08-29 2006-10-05 Swaminathan Jayaraman Drug eluting structurally variable stent
US6849089B2 (en) * 2001-10-08 2005-02-01 Biotronik Mess-Und Therapiegeraete Gmbh & Co Ingenieurbuero Berlin Implant with proliferation-inhibiting substance
US20030125803A1 (en) * 2001-11-13 2003-07-03 Franco Vallana Carrier and kit for intraluminal delivery of active principles or agents
US7014654B2 (en) * 2001-11-30 2006-03-21 Scimed Life Systems, Inc. Stent designed for the delivery of therapeutic substance or other agents
US20040034337A1 (en) * 2002-08-16 2004-02-19 Boulais Dennis R. Microarray drug delivery coatings
US20040044401A1 (en) * 2002-08-30 2004-03-04 Bales Thomas O. Helical stent having improved flexibility and expandability
US20040204750A1 (en) * 2003-04-08 2004-10-14 Medtronic Ave. Drug-eluting stent for controlled drug delivery
US7922756B2 (en) * 2007-12-19 2011-04-12 Boston Scientific Scimed, Inc. Stent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120029622A1 (en) * 2010-08-02 2012-02-02 Baillargeon Brian P Flexible helical stent having different helical regions
US8961590B2 (en) * 2010-08-02 2015-02-24 Cordis Corporation Flexible helical stent having different helical regions

Also Published As

Publication number Publication date
US7922756B2 (en) 2011-04-12
EP2231079A1 (en) 2010-09-29
US20100222868A1 (en) 2010-09-02
WO2009079132A1 (en) 2009-06-25
US7722661B2 (en) 2010-05-25
CN101902993A (en) 2010-12-01
JP2011507604A (en) 2011-03-10
EP2231079B1 (en) 2012-03-21
US20090163991A1 (en) 2009-06-25
ATE550000T1 (en) 2012-04-15
CA2708619A1 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
US7722661B2 (en) Stent
EP2043567B1 (en) Stent design with variable expansion columns along circumference
EP1954223B1 (en) Stent configurations
US8317855B2 (en) Crimpable and expandable side branch cell
US7959668B2 (en) Bifurcated stent
US8211163B2 (en) Hybrid symmetrical stent designs
US8414637B2 (en) Stent
EP2658485B1 (en) Stent
EP2086475B1 (en) Bifurcated stent
US20100292777A1 (en) Stent
EP1962740B1 (en) Improved connectors for bifurcated stent
US20070208411A1 (en) Bifurcated stent with surface area gradient
US20070208414A1 (en) Tapered strength rings on a bifurcated stent petal
US20070208419A1 (en) Bifurcation stent with uniform side branch projection
WO2010005613A1 (en) Overlapping stent

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION